When healthcare providers approach the treatment of obesity, considered a chronic disease, they will follow the latest treatment guidelines, which include considering GLP-1 AOMs for certain high-risk obese individuals
The doctor has also seen an uptick in patients taking GLP-1s to address other conditions beyond obesity and diabetes, like rheumatoid arthritis and cardiovascular disease
For this reason, BPC-157 studies should ideally report analytical verification, solvent conditions, storage conditions, reconstitution approach, experimental timing, concentration or exposure parameters appropriate to the model, and endpoint definitions
Additionally, different races, and distinct diagnostic criteria may be reasons for conflicting results in different studies
Instead, Peaka positions itself as a support supplement that enhances what your body already does